Status:
COMPLETED
Gabapentin in Phantom and Stump Pain
Lead Sponsor:
Danish Pain Research Center
Collaborating Sponsors:
Pfizer
Conditions:
Amputation of Lower Limb
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To investigate whether gabapentin can prevent phantom and stump pain after amputation.
Eligibility Criteria
Inclusion
- 1\. Amputation of crus or femur
Exclusion
- Patients who cannot cooperate
- Fertile women without sufficient contraceptives
- Allergy to gabapentin
- Earlier amputation of the same limb except toes
- Serious lever, kidney, cardiac, respiratory, haematological disease.-
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00169013
Start Date
May 1 2002
End Date
June 1 2006
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Pain Research Center, Aarhus University Hospital
Aarhus, Denmark, 8000